Back
Astellas Pharma Vs. Takeda Pharmaceutical Industry Stock Comparison
Sell
34
ALPMY
Astellas Pharma
Last Price:
9.90
Seasonality Move:
0.67%
Sell
8
TAK
Takeda Pharmaceutical
Last Price:
13.38
Seasonality Move:
-1.44%
Sell
34
Astellas Pharma (ALPMY)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMY] share price is $9.93. The Score for ALPMY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ALPMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Takeda Pharmaceutical (TAK)
is a Sell
Is Takeda Pharmaceutical a Buy, Sell or Hold?
- The current Takeda Pharmaceutical [TAK] share price is $13.06. The Score for TAK is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- TAK is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ALPMY Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $9.93
The current trend is relatively stagnant and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
TAK Stock Price Chart
What is Takeda Pharmaceutical's stock price today?
-
The Takeda Pharmaceutical share price today is $13.06
The current trend is relatively stagnant and TAK is experiencing selling pressure, which indicates risk of future bearish movement.
ALPMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 48.15 | Sell |
| Chaikin Money Flow: | 136203 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.42 - 10.24) | Buy |
| Bollinger Bands (100): | (10.15 - 11.69) | Sell |
TAK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 37.09 | Sell |
| Chaikin Money Flow: | -1172031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.12 - 13.5) | Sell |
| Bollinger Bands (100): | (13.56 - 14.72) | Sell |
ALPMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.87 | Buy |
| 20-day SMA: | 9.67 | Buy |
| 50-day SMA: | 10.35 | Sell |
| 200-day SMA: | 12.27 | Sell |
| 8-day EMA: | 9.89 | Buy |
| 20-day EMA: | 9.89 | Buy |
| 50-day EMA: | 10.27 | Sell |
| 200-day EMA: | 11.89 | Sell |
TAK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.22 | Sell |
| 20-day SMA: | 13.24 | Sell |
| 50-day SMA: | 13.83 | Sell |
| 200-day SMA: | 14.49 | Sell |
| 8-day EMA: | 13.22 | Sell |
| 20-day EMA: | 13.32 | Sell |
| 50-day EMA: | 13.67 | Sell |
| 200-day EMA: | 14.39 | Sell |
Astellas Pharma Earnings Growth & ALPMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Takeda Pharmaceutical Earnings Growth & TAK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Takeda Pharmaceutical Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||